abstract |
Disclosed is a novel method for diagnosing lung cancer. The method involves a step of determining the amount of at least one sugar chain selected from a group consisting of LC35, LC09, LC19, LC42, LC48, LC26, LC15, LC44, LC30, LC38, LC13, LC21 and LC27, the occurrence ratio selected from LC21/LC09, LC19/LC09, LC13/LC09, LC29/LC27, LC19/LC15, LC35/LC05, LC24/LC09, LC19/LC11, LC35/zLC19, LC23/LC09, LC15/LC13 and LC42/LC29, or the like in a patient. |